dc.creatorLühr, Susan
dc.creatorVilches Herrera, Marcelo
dc.creatorFierro, Angélica
dc.creatorRamsay, Rona R.
dc.creatorEdmondson, Dale E.
dc.creatorReyes Parada, Miguel
dc.creatorCassels Niven, Bruce
dc.creatorIturriaga-Vásquez, Patricio
dc.date.accessioned2018-12-20T14:06:16Z
dc.date.available2018-12-20T14:06:16Z
dc.date.created2018-12-20T14:06:16Z
dc.date.issued2010
dc.identifierBioorganic and Medicinal Chemistry, Volumen 18, Issue 4, 2018, Pages 1388-1395
dc.identifier09680896
dc.identifier10.1016/j.bmc.2010.01.029
dc.identifierhttps://repositorio.uchile.cl/handle/2250/153880
dc.description.abstract2-Arylthiomorpholine and 2-arylthiomorpholin-5-one derivatives, designed as rigid and/or non-basic phenylethylamine analogues, were evaluated as rat and human monoamine oxidase inhibitors. Molecular docking provided insight into the binding mode of these inhibitors and rationalized their different potencies. Making the phenylethylamine scaffold rigid by fixing the amine chain in an extended six-membered ring conformation increased MAO-B (but not MAO-A) inhibitory activity relative to the more flexible α-methylated derivative. The presence of a basic nitrogen atom is not a prerequisite in either MAO-A or MAO-B. The best Ki values were in the 10-8 M range, with selectivities towards human MAO-B exceeding 2000-fold. © 2010 Elsevier Ltd. All rights reserved.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceBioorganic and Medicinal Chemistry
dc.subjectAmphetamine
dc.subjectArylthiomorpholine derivatives
dc.subjectDocking
dc.subjectHuman and rat MAO
dc.subjectMAO inhibitors
dc.subjectMonoamine oxidase
dc.title2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución